Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Colombiana de Cardiología
versión impresa ISSN 0120-5633
Resumen
GOMEZ-MESA, Juan E. et al. Thromboprophylaxis, anticoagulation and coagulopathy in times of pandemic: The ACATA, ACMI, SCC CCV and ACMV recommendation. Rev. Colomb. Cardiol. [online]. 2021, vol.28, n.6, pp.539-547. Epub 07-Ene-2022. ISSN 0120-5633. https://doi.org/10.24875/rccar.m21000095.
Introduction
Coronavirus 19 infection can predispose to VTE or arterial thrombosis due to a heightened inflammatory response, hypoxia, immobility and DIC. Up to 20-50% of hospitalized patients with COVID-19 have hematological disorders related to coagulopathies (elevated D-dimer, prolonged PT, thrombocytopenia and/or low fibrinogen). Post-mortem examinations show typical platelet-rich microvascular thrombotic deposits in the small vessels of the lungs and other organs.
Objective
To provide a practical, updated approach to the treatment of patients at high risk for or with ongoing thromboembolic events in the current COVID-19 pandemic setting.
Material and methods
A narrative review was performed including descriptive observational studies. A search of the medical evidence literature was carried out in different search engines such as ScienceDirect and PubMed, using the following key words: thromboprophylaxis, anticoagulation, thrombosis, anticoagulant, COVID-19, SARS-CoV-2, and coronavirus, and general recommendations on the topic were subsequently composed.
Conclusions
The are various ways in which the COVID-19 pandemic may predispose to the development of thrombotic or thromboembolic diseases. The virus may have a direct or indirect effect related to the cytokine storm which triggers the onset of systemic inflammatory response syndrome and predisposes to the development of thrombotic events. The available interventions may also have pharmacological interactions with antiplatelet drugs and/or anticoagulants.
Palabras clave : Thromboprophylaxis; Anticoagulation; Thrombosis; Anticoagulants; COVID-19; Coronavirus.